1. Contact details{View data sources/studies associated with this centre}

Administrative Contact

Scientific Contact

2. Description

The Unit of Adverse Drug reactions Monitoring of the University Hospital of Pisa is a key-element of the Tuscan Regional Centre of Pharmacovigilance. The main activities are represented by: a) Periodic analysis of Italian spontaneous ADR reporting database (in collaboration with Agenzia AIFA and the other Italian Regional Centres of Pharmacovigilance) b) Coordinating or participating centre to project of intensive monitoring of adverse drug reactions for specific drugs or in specific groups of patients. At January 2014, example of projects are: MEREAFaPS: intensive monitoring of adverse drug reactions in Emergency Department (national project coordinated by the Lombardy Region); ASTRAGALUS: registry of patients exposed to treatments with biotechnological drugs for rheumatologic indications (4 rheumatology centres in Tuscany); ANCESTRAL: study on ADRs and drug-drug interactions in elderly patients in primary and secondary care c) Drug safety studies by retrospective analysis of Hospital

3. Category

4. Available resources

5. Therapeutic/disease areas of research in drug safety/risk-benefit performed in the past 5 years

6. Design of drug safety/risk-benefit studies published in the past 5 years

7. Experience in collecting data directly from individual patients/respondents

Number of Studies

8. Access to data collection resources

9. Experience in secondary research and meta-analysis

10. Work with existing data resources in the past 3 years

None

11. Registries established by centre

12. Experience in collaboration in a study team

13. Current involvement in research networks

None

14. Interest in research opportunities which are funded

15. Interest in contract research only if free to publish results

16. Selected publications of the last 5 calendar years